Bank of America’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-100
Closed -$11K 7113
2017
Q2
$11K Buy
+100
New +$10.8K ﹤0.01% 6402
2015
Q2
Sell
-1,000
Closed -$118K 7306
2015
Q1
$118K Sell
1,000
-10,000
-91% -$1.13M ﹤0.01% 5230
2014
Q4
$1.12M Sell
11,000
-13,200
-55% -$1.29M ﹤0.01% 3941
2014
Q3
$2.22M Buy
24,200
+14,200
+142% +$1.23M ﹤0.01% 3293
2014
Q2
$823K Buy
10,000
+1,400
+16% +$107K ﹤0.01% 4151
2014
Q1
$660K Sell
8,600
-8,500
-50% -$663K ﹤0.01% 4323
2013
Q4
$1.18M Buy
17,100
+1,700
+11% +$112K ﹤0.01% 3888
2013
Q3
$998K Buy
15,400
+11,700
+316% +$740K ﹤0.01% 3954
2013
Q2
$215K Buy
+3,700
New +$211K ﹤0.01% 5552

Other funds holding FBT

Bank of America's FBT Position: Q1 2026 in Review

Bank of America increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 5.7% in Q1 2026, buying an estimated $2.24M and bringing the position to 200,959 shares worth $40.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1762.

Bank of America first reported a position in FBT in Q2 2013 and has held it in 52 quarters since. The position peaked at $152M in Q1 2019. 308 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Bank of America held 200,959 shares of First Trust NYSE Arca Biotechnology Index Fund worth $40.4M as of Q1 2026.
  • Bank of America bought 10,853 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $2.24M.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1762 holding.
  • Bank of America first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's First Trust NYSE Arca Biotechnology Index Fund position peaked at $152M in Q1 2019.
  • 308 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.